NCT01209520: Residual Hypermethylation in Early Stage Non-Small Cell Lung Cancer (NSCLC) As Part of Adjuvant Therapy and Preventive Strategy |
|
|
| Completed | N/A | 6 | US | Cisplatin, Platinol®,, cis-diamminedichloroplatinum, Carboplatin, Paraplatin®, Paclitaxel, Taxol, Vidaza, 5-azacitidine, Tumor Specimen for Methylation Analysis, Blood Sample for Methylation Analysis, Vinorelbine, Navelbine®, Docetaxel, Pemetrexed | University of Miami | Lung Cancer, Non Small Cell Lung Carcinoma, Hypermethylation | 12/13 | | | |